Stephen B. Erickson, MD | oneAMYLOIDOSISvoice
Healthcare Professionals

Stephen B. Erickson, MD

Healthcare Professional
Division of Nephrology & Internal Medicine
Mayo Clnic
200 First St. SW
Rochester, Minnesota, United States

Dr. S. Erickson is a graduate in Zoology from University of Illinois. He completed his MD from University of Nebraska Medical School and Residency in Medicine followed by a Fellowship in Nephrology from Mayo Clinic College of Medicine. 

Dr. Erickson is site investigator in Kiacta testing which is a new drug treatment for amyloidosis. He has participated in a trial that showed some efficacy of ingesting oxalate-eating bacteria. Dr. Erickson is co-investigator in a trial of Tolvaptan to see if it dilutes urine and is also participating in trials of Rituxan to induce disease remission.

Stephen B. Erickson is primarily a clinician and teacher and is interested in clinical trials that test new treatments. Dr. Erickson has an experience in treating conditions like amyloidosis, diabetic nephropathy, kidney cyst and kidney stone.


Representative Publications:

How to prescribe loop diuretics in oedema

Elevated admission serum calcium phosphate product as an independent risk factor for acute kidney injury in hospitalized patients

Congophilic Fibrillary Glomerulonephritis: A Case Series 

Outcomes of patients with renal monoclonal immunoglobulin deposition disease 

Incidence and characteristics of kidney stones in patients with horseshoe kidney: A systematic review and meta-analysis 


The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.